US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 397.480
  • -0.220-0.06%
Close Apr 26 16:00 ET
  • 397.420
  • -0.060-0.02%
Post 18:01 ET
102.73BMarket Cap28.62P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.35%3.54B
-78.25%234.6M
32.75%1.27B
-0.47%1.13B
-5.89%899.9M
56.23%4.13B
8.38%1.08B
3.05%955.5M
670.76%1.14B
3.82%956.2M
Net income from continuing operations
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
41.84%3.32B
6.34%818.9M
9.23%930.5M
1,109.70%810.5M
16.69%762.1M
Operating gains losses
-99.60%600K
-93.33%400K
137.13%6.2M
-99.52%400K
-108.47%-6.4M
971.93%149.1M
149.59%6M
64.24%-16.7M
894.34%84.2M
44.55%75.6M
Depreciation and amortization
22.25%181.3M
53.65%59M
14.71%42.1M
10.99%41.4M
8.08%38.8M
18.07%148.3M
13.61%38.4M
15.77%36.7M
19.17%37.3M
24.65%35.9M
Deferred tax
-94.45%-536.5M
-188.45%-131M
36.64%-115.5M
23.02%-176.6M
-821.95%-113.4M
-78.46%-275.9M
453.46%148.1M
-367.30%-182.3M
3.57%-229.4M
-121.58%-12.3M
Other non cash items
5.47%-43.2M
-169.61%-32.3M
32.99%-19.5M
81.46%-11.2M
861.54%19.8M
-504.42%-45.7M
672.84%46.4M
-377.14%-29.1M
-675.24%-60.4M
-62.50%-2.6M
Change In working capital
-177.96%-265.7M
-822.88%-838.9M
133.79%188.9M
-36.04%245.4M
523.48%138.9M
423.95%340.8M
-167.53%-90.9M
188.40%80.8M
333.11%383.7M
-302.47%-32.8M
-Change in receivables
76.55%-84.1M
50.98%15.4M
94.90%-6.1M
96.55%-2.9M
45.22%-90.5M
-30.54%-358.6M
123.45%10.2M
35.51%-119.5M
-260.19%-84.1M
-67.89%-165.2M
-Change in inventory
-136.73%-322.9M
10.60%-70M
-263.81%-97.5M
-118.62%-72.8M
-4,230.00%-82.6M
-46.98%-136.4M
-190.00%-78.3M
-46.45%-26.8M
-34.82%-33.3M
108.77%2M
-Change in prepaid assets
-67.19%-545.7M
-58.63%-451.3M
4.87%-121M
-210.73%-19.6M
-31.66%46.2M
-255.56%-326.4M
-1,889.31%-284.5M
-720.65%-127.2M
122.43%17.7M
608.27%67.6M
-Change in payables and accrued expense
-27.92%478.1M
-39.80%-388.5M
4.02%377.9M
-41.16%312.3M
274.52%176.4M
96.65%663.3M
-364.41%-277.9M
143.83%363.3M
996.62%530.8M
-66.92%47.1M
-Change in other current liabilities
-58.13%208.9M
-89.71%55.5M
495.56%35.6M
159.92%28.4M
469.43%89.4M
2,869.64%498.9M
541.62%539.6M
57.75%-9M
12.71%-47.4M
89.16%15.7M
Cash from discontinued investing activities
Operating cash flow
-14.35%3.54B
-78.25%234.6M
32.75%1.27B
-0.47%1.13B
-5.89%899.9M
56.23%4.13B
8.38%1.08B
3.05%955.5M
670.76%1.14B
3.82%956.2M
Investing cash flow
Cash flow from continuing investing activities
-878.42%-3.14B
-604.84%-886.5M
69.36%-117.7M
-394.15%-303.9M
-3,495.29%-1.83B
5.81%-321.1M
231.04%175.6M
-626.28%-384.2M
22.84%-61.5M
31.36%-51M
Net PPE purchase and sale
2.10%-200.4M
-72.92%-58.1M
25.09%-40.6M
-11.82%-59.6M
33.81%-42.1M
12.89%-204.7M
45.63%-33.6M
-3.44%-54.2M
-6.81%-53.3M
10.30%-63.6M
Net intangibles purchase and sale
---58M
----
----
----
----
--0
----
----
----
----
Net business purchase and sale
--0
--0
----
----
----
---295.9M
--0
----
----
----
Net investment purchase and sale
-1,706.30%-2.88B
-468.26%-770.4M
-126.10%-77.1M
-2,879.27%-244.3M
-14,318.25%-1.79B
269.50%179.5M
389.75%209.2M
-6,720.00%-34.1M
72.48%-8.2M
470.59%12.6M
Cash from discontinued investing activities
Investing cash flow
-878.42%-3.14B
-604.84%-886.5M
69.36%-117.7M
-394.15%-303.9M
-3,495.29%-1.83B
5.81%-321.1M
231.04%175.6M
-626.28%-384.2M
22.84%-61.5M
31.36%-51M
Financing cash flow
Cash flow from continuing financing activities
-730.43%-562.2M
-398.01%-119.8M
-174.09%-165M
-63.73%17.3M
-208.91%-294.7M
95.42%-67.7M
111.96%40.2M
90.83%-60.2M
41.96%47.7M
81.61%-95.4M
Net issuance payments of debt
47.44%-43.1M
-47.83%-10.2M
77.17%-11.3M
13.39%-11M
17.83%-10.6M
-338.50%-82M
-309.09%-6.9M
-345.95%-49.5M
-452.17%-12.7M
-50.00%-12.9M
Net common stock issuance
-280.06%-653.7M
-7,171.43%-152.7M
-254.58%-170.2M
-613.64%-31.4M
-154.81%-299.4M
88.98%-172M
99.43%-2.1M
92.74%-48M
-22.22%-4.4M
77.70%-117.5M
Proceeds from stock option exercised by employees
-27.75%134.6M
-10.08%46.4M
-57.92%15.4M
-9.01%58.6M
-57.86%14.2M
82.65%186.3M
48.70%51.6M
165.22%36.6M
69.92%64.4M
116.03%33.7M
Net other financing activities
----
----
57.14%1.1M
175.00%1.1M
-15.38%1.1M
----
----
-50.00%700K
-75.00%400K
0.00%1.3M
Cash from discontinued financing activities
Financing cash flow
-730.43%-562.2M
-398.01%-119.8M
-174.09%-165M
-63.73%17.3M
-208.91%-294.7M
95.42%-67.7M
111.96%40.2M
90.83%-60.2M
41.96%47.7M
81.61%-95.4M
Net cash flow
Beginning cash position
54.59%10.51B
21.14%11.12B
16.65%10.15B
22.25%9.3B
54.59%10.51B
13.55%6.8B
46.13%9.18B
43.37%8.7B
20.45%7.6B
13.55%6.8B
Current changes in cash
-104.45%-166.6M
-159.63%-771.7M
92.86%985.7M
-24.71%847.8M
-251.69%-1.23B
353.69%3.74B
146.61%1.29B
134.88%511.1M
558.10%1.13B
146.89%809.8M
Effect of exchange rate changes
192.12%26.9M
-32.84%27.4M
41.10%-22.5M
138.61%10M
303.39%12M
-117.91%-29.2M
932.65%40.8M
-349.41%-38.2M
-747.50%-25.9M
-47.50%-5.9M
End cash Position
-1.33%10.37B
-1.33%10.37B
21.14%11.12B
16.65%10.15B
22.25%9.3B
54.59%10.51B
54.59%10.51B
46.13%9.18B
43.37%8.7B
20.45%7.6B
Free cash flow
-16.47%3.28B
-88.66%118.5M
36.23%1.23B
-1.08%1.07B
-3.90%857.8M
62.97%3.93B
11.96%1.04B
3.03%901.3M
535.30%1.09B
5.00%892.6M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.35%3.54B-78.25%234.6M32.75%1.27B-0.47%1.13B-5.89%899.9M56.23%4.13B8.38%1.08B3.05%955.5M670.76%1.14B3.82%956.2M
Net income from continuing operations 8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M41.84%3.32B6.34%818.9M9.23%930.5M1,109.70%810.5M16.69%762.1M
Operating gains losses -99.60%600K-93.33%400K137.13%6.2M-99.52%400K-108.47%-6.4M971.93%149.1M149.59%6M64.24%-16.7M894.34%84.2M44.55%75.6M
Depreciation and amortization 22.25%181.3M53.65%59M14.71%42.1M10.99%41.4M8.08%38.8M18.07%148.3M13.61%38.4M15.77%36.7M19.17%37.3M24.65%35.9M
Deferred tax -94.45%-536.5M-188.45%-131M36.64%-115.5M23.02%-176.6M-821.95%-113.4M-78.46%-275.9M453.46%148.1M-367.30%-182.3M3.57%-229.4M-121.58%-12.3M
Other non cash items 5.47%-43.2M-169.61%-32.3M32.99%-19.5M81.46%-11.2M861.54%19.8M-504.42%-45.7M672.84%46.4M-377.14%-29.1M-675.24%-60.4M-62.50%-2.6M
Change In working capital -177.96%-265.7M-822.88%-838.9M133.79%188.9M-36.04%245.4M523.48%138.9M423.95%340.8M-167.53%-90.9M188.40%80.8M333.11%383.7M-302.47%-32.8M
-Change in receivables 76.55%-84.1M50.98%15.4M94.90%-6.1M96.55%-2.9M45.22%-90.5M-30.54%-358.6M123.45%10.2M35.51%-119.5M-260.19%-84.1M-67.89%-165.2M
-Change in inventory -136.73%-322.9M10.60%-70M-263.81%-97.5M-118.62%-72.8M-4,230.00%-82.6M-46.98%-136.4M-190.00%-78.3M-46.45%-26.8M-34.82%-33.3M108.77%2M
-Change in prepaid assets -67.19%-545.7M-58.63%-451.3M4.87%-121M-210.73%-19.6M-31.66%46.2M-255.56%-326.4M-1,889.31%-284.5M-720.65%-127.2M122.43%17.7M608.27%67.6M
-Change in payables and accrued expense -27.92%478.1M-39.80%-388.5M4.02%377.9M-41.16%312.3M274.52%176.4M96.65%663.3M-364.41%-277.9M143.83%363.3M996.62%530.8M-66.92%47.1M
-Change in other current liabilities -58.13%208.9M-89.71%55.5M495.56%35.6M159.92%28.4M469.43%89.4M2,869.64%498.9M541.62%539.6M57.75%-9M12.71%-47.4M89.16%15.7M
Cash from discontinued investing activities
Operating cash flow -14.35%3.54B-78.25%234.6M32.75%1.27B-0.47%1.13B-5.89%899.9M56.23%4.13B8.38%1.08B3.05%955.5M670.76%1.14B3.82%956.2M
Investing cash flow
Cash flow from continuing investing activities -878.42%-3.14B-604.84%-886.5M69.36%-117.7M-394.15%-303.9M-3,495.29%-1.83B5.81%-321.1M231.04%175.6M-626.28%-384.2M22.84%-61.5M31.36%-51M
Net PPE purchase and sale 2.10%-200.4M-72.92%-58.1M25.09%-40.6M-11.82%-59.6M33.81%-42.1M12.89%-204.7M45.63%-33.6M-3.44%-54.2M-6.81%-53.3M10.30%-63.6M
Net intangibles purchase and sale ---58M------------------0----------------
Net business purchase and sale --0--0---------------295.9M--0------------
Net investment purchase and sale -1,706.30%-2.88B-468.26%-770.4M-126.10%-77.1M-2,879.27%-244.3M-14,318.25%-1.79B269.50%179.5M389.75%209.2M-6,720.00%-34.1M72.48%-8.2M470.59%12.6M
Cash from discontinued investing activities
Investing cash flow -878.42%-3.14B-604.84%-886.5M69.36%-117.7M-394.15%-303.9M-3,495.29%-1.83B5.81%-321.1M231.04%175.6M-626.28%-384.2M22.84%-61.5M31.36%-51M
Financing cash flow
Cash flow from continuing financing activities -730.43%-562.2M-398.01%-119.8M-174.09%-165M-63.73%17.3M-208.91%-294.7M95.42%-67.7M111.96%40.2M90.83%-60.2M41.96%47.7M81.61%-95.4M
Net issuance payments of debt 47.44%-43.1M-47.83%-10.2M77.17%-11.3M13.39%-11M17.83%-10.6M-338.50%-82M-309.09%-6.9M-345.95%-49.5M-452.17%-12.7M-50.00%-12.9M
Net common stock issuance -280.06%-653.7M-7,171.43%-152.7M-254.58%-170.2M-613.64%-31.4M-154.81%-299.4M88.98%-172M99.43%-2.1M92.74%-48M-22.22%-4.4M77.70%-117.5M
Proceeds from stock option exercised by employees -27.75%134.6M-10.08%46.4M-57.92%15.4M-9.01%58.6M-57.86%14.2M82.65%186.3M48.70%51.6M165.22%36.6M69.92%64.4M116.03%33.7M
Net other financing activities --------57.14%1.1M175.00%1.1M-15.38%1.1M---------50.00%700K-75.00%400K0.00%1.3M
Cash from discontinued financing activities
Financing cash flow -730.43%-562.2M-398.01%-119.8M-174.09%-165M-63.73%17.3M-208.91%-294.7M95.42%-67.7M111.96%40.2M90.83%-60.2M41.96%47.7M81.61%-95.4M
Net cash flow
Beginning cash position 54.59%10.51B21.14%11.12B16.65%10.15B22.25%9.3B54.59%10.51B13.55%6.8B46.13%9.18B43.37%8.7B20.45%7.6B13.55%6.8B
Current changes in cash -104.45%-166.6M-159.63%-771.7M92.86%985.7M-24.71%847.8M-251.69%-1.23B353.69%3.74B146.61%1.29B134.88%511.1M558.10%1.13B146.89%809.8M
Effect of exchange rate changes 192.12%26.9M-32.84%27.4M41.10%-22.5M138.61%10M303.39%12M-117.91%-29.2M932.65%40.8M-349.41%-38.2M-747.50%-25.9M-47.50%-5.9M
End cash Position -1.33%10.37B-1.33%10.37B21.14%11.12B16.65%10.15B22.25%9.3B54.59%10.51B54.59%10.51B46.13%9.18B43.37%8.7B20.45%7.6B
Free cash flow -16.47%3.28B-88.66%118.5M36.23%1.23B-1.08%1.07B-3.90%857.8M62.97%3.93B11.96%1.04B3.03%901.3M535.30%1.09B5.00%892.6M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+0.41%